Works matching IS 13524585 AND DT 2022 AND VI 28 AND IP 12

Results: 18
    1
    2
    3
    4
    5
    6
    7

    Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial.

    Published in:
    Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1944, doi. 10.1177/13524585221102584
    By:
    • Cree, Bruce AC;
    • Selmaj, Krzysztof W;
    • Steinman, Lawrence;
    • Comi, Giancarlo;
    • Bar-Or, Amit;
    • Arnold, Douglas L;
    • Hartung, Hans-Peter;
    • Montalbán, Xavier;
    • Havrdová, Eva K;
    • Sheffield, James K;
    • Minton, Neil;
    • Cheng, Chun-Yen;
    • Silva, Diego;
    • Kappos, Ludwig;
    • Cohen, Jeffrey A
    Publication type:
    Article
    8

    Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients.

    Published in:
    Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1937, doi. 10.1177/13524585221102158
    By:
    • Guerrera, Gisella;
    • Mandelli, Alessandra;
    • Finardi, Annamaria;
    • Orrico, Mario;
    • D'Orso, Silvia;
    • Picozza, Mario;
    • Noviello, Maddalena;
    • Beretta, Valeria;
    • Bonetti, Bruno;
    • Calabrese, Massimiliano;
    • Marastoni, Damiano;
    • De Rossi, Nicola;
    • Capra, Ruggero;
    • Salvetti, Marco;
    • Buscarinu, Maria Chiara;
    • Inglese, Matilde;
    • Uccelli, Antonio;
    • Moiola, Lucia;
    • Raposo, Catarina;
    • Muros-Le Rouzic, Erwan
    Publication type:
    Article
    9
    10
    11
    12
    13
    14

    Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis.

    Published in:
    Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1859, doi. 10.1177/13524585221097296
    By:
    • Brune, Synne;
    • Høgestøl, Einar A;
    • de Rodez Benavent, Sigrid A;
    • Berg-Hansen, Pål;
    • Beyer, Mona K;
    • Leikfoss, Ingvild Sørum;
    • Bos, Steffan D;
    • Sowa, Piotr;
    • Brunborg, Cathrine;
    • Andorra, Magi;
    • Pulido Valdeolivas, Irene;
    • Asseyer, Susanna;
    • Brandt, Alexander;
    • Chien, Claudia;
    • Scheel, Michael;
    • Blennow, Kaj;
    • Zetterberg, Henrik;
    • Kerlero de Rosbo, Nicole;
    • Paul, Friedemann;
    • Uccelli, Antonio
    Publication type:
    Article
    15
    16
    17

    Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS.

    Published in:
    Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1927, doi. 10.1177/13524585221097561
    By:
    • Arnold, Douglas L;
    • Sprenger, Till;
    • Bar-Or, Amit;
    • Wolinsky, Jerry S;
    • Kappos, Ludwig;
    • Kolind, Shannon;
    • Bonati, Ulrike;
    • Magon, Stefano;
    • van Beek, Johan;
    • Koendgen, Harold;
    • Bortolami, Oscar;
    • Bernasconi, Corrado;
    • Gaetano, Laura;
    • Traboulsee, Anthony
    Publication type:
    Article
    18

    Lesion size and shape in central vein sign assessment for multiple sclerosis diagnosis: An in vivo and postmortem MRI study.

    Published in:
    Multiple Sclerosis Journal, 2022, v. 28, n. 12, p. 1891, doi. 10.1177/13524585221097560
    By:
    • Al-Louzi, Omar;
    • Manukyan, Sargis;
    • Donadieu, Maxime;
    • Absinta, Martina;
    • Letchuman, Vijay;
    • Calabresi, Brent;
    • Desai, Parth;
    • Beck, Erin S;
    • Roy, Snehashis;
    • Ohayon, Joan;
    • Pham, Dzung L;
    • Thomas, Anish;
    • Jacobson, Steven;
    • Cortese, Irene;
    • Auluck, Pavan K;
    • Nair, Govind;
    • Sati, Pascal;
    • Reich, Daniel S
    Publication type:
    Article